The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis

PURPOSE: About 20–25% of patients experience weight regain (WR) or insufficient weight loss (IWL) after bariatric metabolic surgery (BS). Therefore, we aimed to retrospectively assess the effectiveness of adjunct treatment with the GLP-1 receptor agonist semaglutide in non-diabetic patients with WR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautenbach, Anne, Wernecke, Marie, Huber, Tobias B., Stoll, Fabian, Wagner, Jonas, Meyhöfer, Sebastian M., Meyhöfer, Svenja, Aberle, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532334/
https://www.ncbi.nlm.nih.gov/pubmed/35879524
http://dx.doi.org/10.1007/s11695-022-06211-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532334/
https://www.ncbi.nlm.nih.gov/pubmed/35879524
http://dx.doi.org/10.1007/s11695-022-06211-9

Ejemplares similares